Abstract
This thesis aims to develop an adequate method of CTA to influence decision making about the development and clinical application of a medical technology. The adequacy of this method is related to the timing of its application, the information used in the assessment, the consensus formation about, and the quality of the assessment outcomes. This method of CTA should be applied before the clinical introduction of the medical technology. The timing of application during the development stage of the technology needs to attune to the dynamics of technological change. Furthermore, this method is to evaluate the quality of a technology based on a comprehensive set of criteria. This evaluation needs to reflect the perspectives about the quality of the technology of the various actors that shape technological development and clinical application. These actors need to be satisfied with the degree of consensus they attain about the outcomes, and the quality of the outcomes. In addition, the outcomes need to be of sufficient quality for these actors to derive practical guidelines that effectively enhance the technology’s later quality in clinical practice.
Keywords
Related Publications
Technological frames
In this article, we build on and extend research into the cognitions and values of users and designers by proposing a systematic approach for examining the underlying assumption...
Knowledge Driven Quality Improvement
Little is known about the processes that make TQM effective. Why are some quality improvement projects more effective than others? We argue that TQM processes affect the way peo...
CT/CT Angiography and MRI Findings Predict Recurrent Stroke After Transient Ischemic Attack and Minor Stroke
Background and Purpose— Transient ischemic attack and minor stroke portend a substantial risk of recurrent stroke. MRI can identify patients at high risk for a recurrent stroke....
Clinical End Points in Coronary Stent Trials
Background— Although most clinical trials of coronary stents have measured nominally identical safety and effectiveness end points, differences in definitions and timing of asse...
Classification of the cutaneous manifestations of <scp>COVID</scp> ‐19: a rapid prospective nationwide consensus study in Spain with 375 cases
We provide a description of the cutaneous manifestations associated with COVID-19 infection. These may help clinicians approach patients with the disease and recognize cases pre...
Publication Info
- Year
- 2001
- Type
- article
- Citations
- 15
- Access
- Closed